Is Falcine Meningioma a Diffuse Disease of the Falx? Case Series and Analysis of a "Grade Zero" Resection

Michael A Mooney1,2, Mohammad Abolfotoh3,4, Wenya Linda Bi2

  • 1Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona.

Neurosurgery
|April 16, 2020
PubMed
Abstract

Insights

Complete resection of falcine meningiomas, especially "Grade Zero" resection, significantly reduces recurrence and improves progression-free survival (PFS). This approach is crucial for managing these challenging brain tumors.

Area of Science:

  • Neurosurgery
  • Oncology
  • Pathology

Background:

  • Falcine meningiomas present unique challenges, including high recurrence rates, association with high-grade pathology, male predominance, and diffuse involvement of the falx.
  • These characteristics necessitate specific surgical considerations and outcome assessments.

Purpose of the Study:

  • To analyze a substantial series of falcine meningiomas.
  • To report on the impact of the extent of surgical resection on recurrence and survival for this distinct meningioma entity.

Main Methods:

  • Retrospective analysis of 59 patients with falcine meningiomas who underwent surgery.
  • Classification of resection extent, including a
  • Grade Zero
  • category for achieving a 2-3 cm clear margin from tumor insertion.
  • Evaluation of recurrence rates and progression-free survival (PFS).

Main Results:

  • Gross total resection (GTR) significantly decreased recurrence for de novo falcine meningiomas compared to subtotal resection (P ≤ .0001).
  • For recurrent meningiomas, GTR significantly improved median PFS (37 months vs. 12 months; P = .017).
  • "Grade Zero" resection demonstrated excellent durability and significantly improved PFS for recurrent cases (P = .003).

Conclusions:

  • Falcine meningioma recurrence is linked to diffuse tumor infiltration within the falx.
  • Increased extent of resection, including a clear margin of the falx, is associated with the best long-term outcomes, particularly for recurrent tumors.

Related Concept Videos